Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3506910015 | Azithromycin monohydrate (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3506911016 | Azithromycin monohydrate | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Azithromycin monohydrate | Is a | Azithromycin | false | Inferred relationship | Existential restriction modifier | ||
| Azithromycin monohydrate | Is modification of | Azithromycin | true | Inferred relationship | Existential restriction modifier | ||
| Azithromycin monohydrate | Is a | Substance with macrolide structure and antibacterial mechanism of action | true | Inferred relationship | Existential restriction modifier | ||
| Azithromycin monohydrate | Has disposition | Antibacterial | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely azithromycin anhydrous (as azithromycin monohydrate) 10 milligram/1 milliliter conventional release eye solution (clinical drug) | Has precise active ingredient | False | Azithromycin monohydrate | Inferred relationship | Existential restriction modifier | 1 |
| Product containing precisely azithromycin anhydrous (as azithromycin monohydrate) 20 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | False | Azithromycin monohydrate | Inferred relationship | Existential restriction modifier | 1 |
This concept is not in any reference sets
FHIR